Zacks.com on MSN12h
Regeneron Gets Positive CHMP Opinion for Multiple Myeloma DrugThe CHMP recommends conditional marketing authorization of REGN's linvoseltamab to treat adults with relapsed and refractory multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback